Nyah Phengsitthy

Health Reporter at Bloomberg Law

washington, district of columbia, united states

Publications:

nnews.bgov.com

nnews.bloomberglaw.com

nnews.bloombergtax.com

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

About

I'm a health reporter for Bloomberg Law writing about the US Food and Drug Administration, drug pricing provisions under the Inflation Reduction Act, 340B Drug Pricing Program, and litigation trends/developments in the pharmaceutical and health-care industry.

Featured Articles

Boehringer Asks High Court to Weigh US Drug Price Negotiations

The petition urges the justices to review a decision from the US Court of Appeals for the Second Circuit that dealt a blow last year to the drugmaker’s challenge against the Medicare Drug Price Negotiation Program. “The Program’s scope and scale alone mak... See more

bloombergtax.com•Nyah Phengsitthy•Jan 8, 2026

New US Vaccine Guidance for Kids Raises Risk for Injury Program

The Trump administration’s unprecedented decision to slash the number of recommended vaccines for children opens the door to changes in a program for individuals seeking compensation from drug manufacturers over immunization injuries. The Centers for Dise... See more

bloomberglaw.com•Nyah Phengsitthy•Jan 8, 2026

Eli Lilly Joins Trump Program Expanding Obesity Drug Access

Consistent with a November 2025 agreement with the Trump administration to expand access to obesity medicines and reduce patient costs, “Lilly plans to participate in the voluntary BALANCE model to expand access to GLP-1s in both Medicare and Medicaid,” a... See more

bgov.com•Nyah Phengsitthy•Jan 7, 2026

First Circuit Rejects Trump's Move to Slash NIH Research Funds

The Trump administration’s attempt to slash billions in NIH research overhead costs was rejected by a federal appeals court Monday, dealing a blow to the government’s broad cuts to federal spending. The US Court of Appeals for the First Circuit affirmed t... See more

bloombergtax.com•Nyah Phengsitthy•Jan 5, 2026

RFK Jr.'s FDA Adds to Agenda Putting Pressure on Vaccine Access

The FDA has played an active role in US Health Secretary Robert F. Kennedy Jr.’s agenda to scrutinize vaccines, even if the moves haven’t been as deeply examined as those at agencies like the CDC, immunization experts say. Kennedy moved rapidly in 2025 to... See more

bloomberglaw.com•Nyah Phengsitthy•Jan 2, 2026

Bylined Articles

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

2K +

Articles41

Last Article5 days ago

Stats

Education

Bachelors, Communication, Design at Elon UniversityGraduated: 2023

Education

Nyah Phengsitthy

Is this you?

About

Featured Articles

Boehringer Asks High Court to Weigh US Drug Price Negotiations

New US Vaccine Guidance for Kids Raises Risk for Injury Program

Eli Lilly Joins Trump Program Expanding Obesity Drug Access

First Circuit Rejects Trump's Move to Slash NIH Research Funds

RFK Jr.'s FDA Adds to Agenda Putting Pressure on Vaccine Access

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Featured Articles

Boehringer Asks High Court to Weigh US Drug Price Negotiations

New US Vaccine Guidance for Kids Raises Risk for Injury Program

Eli Lilly Joins Trump Program Expanding Obesity Drug Access

First Circuit Rejects Trump's Move to Slash NIH Research Funds

RFK Jr.'s FDA Adds to Agenda Putting Pressure on Vaccine Access

Social Media

Education